Pharmaceuticals

Pharmaceuticals articles from Informachine.

Zydus Lifesciences acquires Assertio in ₹1,570 crore US expansion push

By Cygnus | 14 May 2026

Zydus Lifesciences will acquire US-based Assertio Holdings for about $166 million, expanding its oncology and specialty pharmaceutical business in the United States.

Novartis expands India’s role in global drug development and R&D

By Axel Miller | 11 May 2026

Novartis is expanding India’s role in pharmaceutical R&D, clinical research and innovative medicines following its strategic restructuring in the country.

Novo Nordisk explores AI partnerships to accelerate drug discovery and manufacturing efficiency

By Cygnus | 14 Apr 2026

Novo Nordisk and global pharma firms are adopting AI to improve drug discovery, manufacturing efficiency, and clinical research in obesity treatments.

Indian drugmakers prepare lower-cost versions of Ozempic-like drugs as competition intensifies

By Axel Miller | 23 Mar 2026

Indian pharma companies prepare affordable semaglutide alternatives as demand for diabetes and weight-loss treatments grows in India.

India sees early competition in semaglutide as drugmakers prepare lower-cost versions

By Axel Miller | 20 Mar 2026

Indian pharmaceutical companies are exploring lower-cost semaglutide options, aiming to expand access to diabetes and obesity treatments.

Zydus and Lupin partner to co-market semaglutide injections in India

By Cygnus | 17 Mar 2026

Zydus and Lupin sign a licensing deal to co-market semaglutide injections in India, introducing a reusable pen device for diabetes and weight-management therapy.

CDSCO warns pharma firms over ‘surrogate’ ads for obesity drugs

By Axel Miller | 12 Mar 2026

CDSCO warns pharma firms against indirect promotion of GLP-1 weight-loss drugs ahead of generic launches.

Sun Pharma Gets DCGI Nod for Generic Wegovy, Set for March Launch as Semaglutide Patent Nears Expiry

By Axel Miller | 23 Jan 2026

Sun Pharma has received DCGI approval for generic semaglutide for weight management and will launch Noveltreat after the semaglutide patent expires in March 2026.

Sun Pharma Weighs $10 Billion Takeover of Organon to Expand US Footprint

By Cygnus | 19 Jan 2026

Sun Pharma is evaluating a ~$10B acquisition of Organon to expand its U.S. footprint in women's health and biosimilars, according to reports.

Johnson & Johnson Cuts Drug Prices to Secure Tariff Exemptions in Trump Deal

By Cygnus | 09 Jan 2026

Johnson & Johnson agrees to cut U.S. drug prices in exchange for tariff relief from the Trump administration and plans new factories in North Carolina and Pennsylvania.

Page no. 1 of 131

1
2
3
4
5
6
7
8
9
10
Next
Last

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!